PEOPLE - Beckman Coulter makes appointment:
This article was originally published in Clinica
US clinical diagnostics and biomedical research firm Beckman Coulter (Fullerton, California) has named CEO and company president Scott Garrett as chairman of the board, effective from April 24 2008. To take effect on the same date, non-executive chair Betty Woods will become lead independent director.
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.